# SHIFT: Studying HIV Immunology After Fecal Transplant

> **NCT03163784** · PHASE1,PHASE2 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- HIV/AIDS
- Dysbiosis
- Inflammation

## Interventions

- **BIOLOGICAL:** Fecal Inoculum Capsule
- **BIOLOGICAL:** Placebo (for Fecal Inoculum Capsule)
- **DRUG:** Antibiotic
- **DRUG:** Antibiotic Placebo

## Key facts

- **NCT ID:** NCT03163784
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-06
- **Primary completion:** 2020-06
- **Final completion:** 2022-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study closed because of shifting research priorities and interests.
- **Last updated:** 2018-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03163784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03163784, "SHIFT: Studying HIV Immunology After Fecal Transplant". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03163784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*